ID MAGF1_HUMAN Reviewed; 307 AA. AC Q9HAY2; Q9H215; DT 02-NOV-2001, integrated into UniProtKB/Swiss-Prot. DT 13-JUL-2010, sequence version 2. DT 05-FEB-2025, entry version 148. DE RecName: Full=Melanoma-associated antigen F1 {ECO:0000305}; DE Short=MAGE-F1 {ECO:0000303|PubMed:11313144, ECO:0000303|PubMed:29225034}; DE AltName: Full=MAGE-F1 antigen; GN Name=MAGEF1 {ECO:0000312|HGNC:HGNC:29639}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY. RX PubMed=11313144; DOI=10.1016/s0378-1119(01)00406-1; RA Stone B., Schummer M., Paley P.J., Crawford M., Ford M., Urban N., RA Nelson B.H.; RT "MAGE-F1, a novel ubiquitously expressed member of the MAGE superfamily."; RL Gene 267:173-182(2001). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16641997; DOI=10.1038/nature04728; RA Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J., RA Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., RA Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., RA Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L., RA Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G., RA Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W., RA Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., RA Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P., RA Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H., RA Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J., RA Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W., RA Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B., RA Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., RA Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B., RA Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H., RA Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J., RA Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X., RA Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R., RA Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.; RT "The DNA sequence, annotation and analysis of human chromosome 3."; RL Nature 440:1194-1198(2006). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP NUCLEOTIDE SEQUENCE [MRNA] OF 1-283. RC TISSUE=Kidney; RX PubMed=11454705; RA Chomez P., De Backer O., Bertrand M., De Plaen E., Boon T., Lucas S.; RT "An overview of the MAGE gene family with the identification of all human RT members of the family."; RL Cancer Res. 61:5544-5551(2001). RN [5] RP FUNCTION, AND INTERACTION WITH LNX1; TRIM27 AND NSMCE1. RX PubMed=20864041; DOI=10.1016/j.molcel.2010.08.029; RA Doyle J.M., Gao J., Wang J., Yang M., Potts P.R.; RT "MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases."; RL Mol. Cell 39:963-974(2010). RN [6] RP FUNCTION, INTERACTION WITH NSMCE1, AND MUTAGENESIS OF 87-LYS-LYS-88. RX PubMed=29225034; DOI=10.1016/j.molcel.2017.11.010; RA Weon J.L., Yang S.W., Potts P.R.; RT "Cytosolic Iron-Sulfur Assembly Is Evolutionarily Tuned by a Cancer- RT Amplified Ubiquitin Ligase."; RL Mol. Cell 69:113-125(2018). CC -!- FUNCTION: Enhances ubiquitin ligase activity of RING-type zinc finger- CC containing E3 ubiquitin ligases. Proposed to act through recruitment CC and/or stabilization of the E2 ubiquitin-conjugating enzyme at the CC E3:substrate complex. MAGEF1-NSMCE1 ubiquitin ligase complex promotes CC proteasomal degradation of MMS19, a key component of the cytosolic CC iron-sulfur protein assembly (CIA) machinery. Down-regulation of MMS19 CC impairs the activity of several DNA repair and metabolism enzymes such CC as ERCC2/XPD, FANCJ, RTEL1 and POLD1 that require iron-sulfur clusters CC as cofactors. May negatively regulate genome integrity by inhibiting CC homologous recombination-mediated double-strand break DNA repair CC (PubMed:29225034). {ECO:0000269|PubMed:20864041, CC ECO:0000269|PubMed:29225034}. CC -!- SUBUNIT: Interacts (via MAGE domain) with RING-type zinc finger- CC containing E3 ubiquitin-protein ligases LNX1, TRIM27 and NSMCE1; the CC interaction is direct. {ECO:0000269|PubMed:20864041, CC ECO:0000269|PubMed:29225034}. CC -!- INTERACTION: CC Q9HAY2; Q99750: MDFI; NbExp=4; IntAct=EBI-5525855, EBI-724076; CC Q9HAY2; Q8WV22: NSMCE1; NbExp=2; IntAct=EBI-5525855, EBI-2557372; CC -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:11313144}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF295378; AAG30208.1; -; mRNA. DR EMBL; AC107294; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC010056; AAH10056.1; -; mRNA. DR EMBL; AF320910; AAG38606.1; -; mRNA. DR CCDS; CCDS3269.1; -. DR RefSeq; NP_071432.2; NM_022149.4. DR AlphaFoldDB; Q9HAY2; -. DR SMR; Q9HAY2; -. DR BioGRID; 122067; 35. DR IntAct; Q9HAY2; 19. DR STRING; 9606.ENSP00000315064; -. DR iPTMnet; Q9HAY2; -. DR PhosphoSitePlus; Q9HAY2; -. DR BioMuta; MAGEF1; -. DR DMDM; 300669649; -. DR jPOST; Q9HAY2; -. DR MassIVE; Q9HAY2; -. DR PaxDb; 9606-ENSP00000315064; -. DR PeptideAtlas; Q9HAY2; -. DR ProteomicsDB; 81457; -. DR Pumba; Q9HAY2; -. DR Antibodypedia; 33826; 204 antibodies from 28 providers. DR DNASU; 64110; -. DR Ensembl; ENST00000317897.5; ENSP00000315064.3; ENSG00000177383.5. DR GeneID; 64110; -. DR KEGG; hsa:64110; -. DR MANE-Select; ENST00000317897.5; ENSP00000315064.3; NM_022149.5; NP_071432.2. DR UCSC; uc003fpa.4; human. DR AGR; HGNC:29639; -. DR CTD; 64110; -. DR DisGeNET; 64110; -. DR GeneCards; MAGEF1; -. DR HGNC; HGNC:29639; MAGEF1. DR HPA; ENSG00000177383; Low tissue specificity. DR MIM; 609267; gene. DR neXtProt; NX_Q9HAY2; -. DR OpenTargets; ENSG00000177383; -. DR PharmGKB; PA134920978; -. DR VEuPathDB; HostDB:ENSG00000177383; -. DR eggNOG; KOG4562; Eukaryota. DR GeneTree; ENSGT00940000163736; -. DR HOGENOM; CLU_039582_2_0_1; -. DR InParanoid; Q9HAY2; -. DR OMA; TNPPEYE; -. DR OrthoDB; 205198at2759; -. DR PhylomeDB; Q9HAY2; -. DR TreeFam; TF328505; -. DR PathwayCommons; Q9HAY2; -. DR SignaLink; Q9HAY2; -. DR BioGRID-ORCS; 64110; 12 hits in 1156 CRISPR screens. DR ChiTaRS; MAGEF1; human. DR GenomeRNAi; 64110; -. DR Pharos; Q9HAY2; Tdark. DR PRO; PR:Q9HAY2; -. DR Proteomes; UP000005640; Chromosome 3. DR RNAct; Q9HAY2; protein. DR Bgee; ENSG00000177383; Expressed in ganglionic eminence and 192 other cell types or tissues. DR GO; GO:0005634; C:nucleus; IBA:GO_Central. DR GO; GO:2000042; P:negative regulation of double-strand break repair via homologous recombination; IDA:UniProtKB. DR GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IBA:GO_Central. DR GO; GO:2000060; P:positive regulation of ubiquitin-dependent protein catabolic process; IDA:UniProtKB. DR GO; GO:0097428; P:protein maturation by iron-sulfur cluster transfer; IDA:UniProtKB. DR GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB. DR FunFam; 1.10.10.1200:FF:000003; MAGE family member F1; 1. DR FunFam; 1.10.10.1210:FF:000001; melanoma-associated antigen D1; 1. DR Gene3D; 1.10.10.1200; MAGE homology domain, winged helix WH1 motif; 1. DR Gene3D; 1.10.10.1210; MAGE homology domain, winged helix WH2 motif; 1. DR InterPro; IPR037445; MAGE. DR InterPro; IPR041898; MAGE_WH1. DR InterPro; IPR041899; MAGE_WH2. DR InterPro; IPR002190; MHD_dom. DR PANTHER; PTHR11736:SF61; MELANOMA-ASSOCIATED ANTIGEN F1; 1. DR PANTHER; PTHR11736; MELANOMA-ASSOCIATED ANTIGEN MAGE ANTIGEN; 1. DR Pfam; PF01454; MAGE; 1. DR SMART; SM01373; MAGE; 1. DR PROSITE; PS50838; MAGE; 1. PE 1: Evidence at protein level; KW Proteomics identification; Reference proteome; Tumor antigen; KW Ubl conjugation pathway. FT CHAIN 1..307 FT /note="Melanoma-associated antigen F1" FT /id="PRO_0000156732" FT DOMAIN 76..277 FT /note="MAGE" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00127" FT REGION 1..55 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 16..27 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 35..48 FT /note="Basic and acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT VARIANT 93 FT /note="K -> R (in dbSNP:rs34540780)" FT /id="VAR_057651" FT MUTAGEN 87..88 FT /note="Missing: Loss of interaction with NSMCE1." FT /evidence="ECO:0000269|PubMed:29225034" FT CONFLICT 66 FT /note="A -> S (in Ref. 1; AAG30208, 2; AAG38606 and 3; FT AAH10056)" FT /evidence="ECO:0000305" FT CONFLICT 158 FT /note="E -> EE (in Ref. 1; AAG30208, 2; AAG38606 and 3; FT AAH10056)" FT /evidence="ECO:0000305" FT CONFLICT 236 FT /note="E -> A (in Ref. 1; AAG30208, 2; AAG38606 and 3; FT AAH10056)" FT /evidence="ECO:0000305" SQ SEQUENCE 307 AA; 35222 MW; 8CB673B3FF7921EE CRC64; MLQTPESRGL PVPQAEGEKD GGHDGETRAP TASQERPKEE LGAGREEGAA EPALTRKGAR ALAAKALARR RAYRRLNRTV AELVQFLLVK DKKKSPITRS EMVKYVIGDL KILFPDIIAR AAEHLRYVFG FELKQFDRKH HTYILINKLK PLEEEEEEDL GGDGPRLGLL MMILGLIYMR GNSAREAQVW EMLRRLGVQP SKYHFLFGYP KRLIMEDFVQ QRYLSYRRVP HTNPPEYEFS WGPRSNLEIS KMEVLGFVAK LHKKEPQHWP VQYREALADE ADRARAKARA EASMRARASA RAGIHLW //